P. M. Mumford et al. / Tetrahedron Letters 49 (2008) 3489–3491
3491
1
3. Rabindran, S. K.; Ross, D. D.; Doyle, L. A.; Yang, W.; Greenberger,
L. M. Cancer Res. 2000, 60, 47–50.
mixture by H NMR indicated the presence of a second
component tentatively assigned as the minor diastereomer
(dr = 8:1) which was not isolated. The relative stereo-
chemistry of 8 was deduced by NOESY experiments.15
In summary, a new approach to 1,1-disubstituted tetra-
hydro-b-carbolines has been devised based upon the ring
opening of indole substituted methyleneaziridines. Studies
to extend this reaction to other types of nucleophiles are
ongoing in our laboratories and will be disclosed in due
course.
4. Patil, A. D.; Freyer, A. J.; Carte, B.; Taylor, P. B.; Johnson, R. K.;
Faulkner, D. J. J. Nat. Prod. 2002, 65, 628–629.
5. For recent illustrative examples of the use of THBCs in drug
discovery, see: (a) Trujillo, J. I.; Meyers, M. J.; Anderson, D. R.;
Hegde, S.; Mahoney, M. W.; Vernier, W. F.; Buchler, I. P.; Wu, K.
K.; Yang, S.; Hartmann, S. J.; Reitz, D. B. Bioorg. Med. Chem. Lett.
2007, 17, 4657–4663; (b) Chen, C.-H.; Chang, C.-M.; Chen, H.-Y.;
Lai, J.-J.; Sun, C.-M. J. Comb. Chem. 2007, 9, 618–626; (c) Diness, F.;
Beyer, J.; Meldal, M. Chem. Eur. J. 2006, 12, 8056–8066; (d) Lee,
S.-C.; Choi, S. Y.; Chung, Y. K.; Park, S.-B. Tetrahedron Lett. 2006,
47, 6843–6847; (e) Sunder-Plassmann, N.; Sarli, V.; Gartner, M.; Utz,
M.; Seiler, J.; Huemmer, S.; Mayer, T. U.; Surrey, T.; Giannis, A.
Bioorg. Med. Chem. Lett. 2005, 13, 6094–6111.
Acknowledgements
6. (a) Daugan, A.; Grondin, P.; Ruault, C.; Le Monnier de Gouville,
This work was supported by the Engineering and
Physical Sciences Research Council, the Biotechnology
and Biological Sciences Research Council (BBSSL-
200512206), Organon and GlaxoSmithKline. We are
indebted to the EPSRC National Mass Spectrometry
Service Centre for performing some of the mass measure-
ments, and to EPSRC (EP/C007999/1) for the provision
of additional mass spectrometers.
`
A.-C.; Coste, H.; Kirilovsky, J.; Hyafil, F.; Labaudiniere, R. J. Med.
Chem. 2003, 46, 4525–4532; (b) Daugan, A.; Grondin, P.; Ruault, C.;
Le Monnier de Gouville, A.-C.; Coste, H.; Linget, J.-M.; Kirilovsky,
`
J.; Hyafil, F.; Labaudiniere, R. J. Med. Chem. 2003, 46, 4533–4542.
7. Herraiz, T.; Galisteo, J.; Chamorro, C. J. Agric. Food Chem. 2003, 51,
2168–2173.
8. For a review, see: Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797–
1842.
9. For alternative strategies to THBCs, see: Bandini, M.; Melloni, A.;
Piccinelli, F.; Sinisi, R.; Tommasi, S.; Umani-Ronchi, A. J. Am.
Chem. Soc. 2006, 128, 1424–1425 and references cited therein.
10. Lingam, Y.; Rao, D. M.; Bhowmik, D. R.; Santu, P. S.; Rao, K. R.;
Islam, A. Tetrahedron Lett. 2007, 48, 7243–7245.
Supplementary data
Supplementary data (experimental procedures and
characterisation data for 2a–c, 3a–c, 4a–i and 6–8) associ-
ated with this article can be found, in the online version,
11. Horiguchi, Y.; Nakamura, M.; Kida, A.; Kodama, H.; Saitoh, T.;
Sano, T. Heterocycles 2003, 59, 691–705.
12. Shiers, J. J.; Shipman, M.; Hayes, J. F.; Slawin, A. M. Z.; Twin, H. J.
Am. Chem. Soc. 2004, 126, 6868–6869 and references cited therein.
13. Prepared by adaption of a recent synthesis of N-benzyltryptamine by:
Liu, Y.; Luo, S.; Fu, X.; Fang, F.; Zhuang, Z.; Xiong, W.; Jia, X.;
Zhai, H. Org. Lett. 2006, 8, 115–118.
References and notes
14. Hayes, J. F.; Shipman, M.; Twin, H. J. Org. Chem. 2002, 67, 935–942.
15. Strong NOESY cross-peaks were seen between the Me group at C-1
and H-3, and between the CH2OBn group and the methyl group at
C-3. These data are consistent with the depicted (1R*,3R*)-
diastereomer.
1. Greenhill, J. V. In Comprehensive Heterocyclic Chemistry; Katritzky,
A. R., Rees, C. W., Bird, C. W., Cheeseman, G. W. H., Eds.;
Pergamon Press: Oxford, 1984; Vol. 4.
2. Kam, T.-S.; Sim, K.-M. Phytochemistry 1998, 47, 145–147.